Aesthetic Medical International Hldngs Group Ltd Sponsored ADR

PAIYY Healthcare Medical Care Facilities

In the quarter to June 2025, revenue grew 25,427.4% and EPS grew 76.8%, each against the same quarter a year earlier.

0.01 0.00 0.00%
Market cap
$15.9M
P/E
0.0×
Fwd P/E
8.3×
Dividend yield
—
F-score
5/9
Altman Z
n/a
Beneish M
−2.30
Dividend safety
12/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — — — 1 2 5 5 5 5
P/E ratio
13.37 13.37 13.37 17.35 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.00 0.00 0.00 0.00 0.88 0.50 0.38 0.32 0.13 0.05
P/FCF ratio
0.00 0.00 0.00 5.64 9.95 15.61 0.00 0.00 0.00 0.00
Beneish M-Score
— — — (2.58) (3.29) (9.56) (2.48) (3.39) (3.56) (2.30)
P/Operating CF
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/B ratio
0.00 0.00 0.00 1.16 1.86 5.16 0.00 6.54 10.59 31.46
Dividend Safety Score
— — — — — — — — — 12
Price to Tangible BV
0.00 0.00 0.00 1.71 3.64 12.96 0.00 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 0.00 1.09 0.68 0.66 0.40 0.21 0.09
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
0.00 0.00 0.00 7.31 12.37 21.08 (29.00) (15.77) (10.71) (6.87)
EV/FCF
0.00 0.00 0.00 7.31 12.37 21.08 (2.41) (1.31) (0.89) (0.57)
Quick Ratio
— 1.12 1.50 0.90 0.57 0.15 0.09 0.23 0.18 0.27
Current Ratio
— 1.71 1.65 1.00 0.68 0.21 0.14 0.27 0.22 0.31
Net Debt/EBITDA
0.00 4.03 0.67 (0.16) (2.21) (0.98) 12.06 1.68 0.68 1.81
Debt/Assets
— 0.00% 24.77% 13.41% 23.69% 47.12% 36.95% 18.79% 17.67% 28.24%
Debt/Equity
— (10.37) (0.67) 0.24 0.58 (1.46) (1.60) 3.13 9.20 (3.34)
Asset Turnover
0.00 1.10 2.25 0.99 0.87 0.83 1.17 1.20 1.43 1.45
Operating CF/Net income
0.98 (0.93) (0.12) 0.64 0.00 (0.09) 0.99 (1.98) (3.99) 0.23
Capex/Depreciation
0.00 0.00 (2.42) (0.91) (0.42) (0.34) (0.03) (0.84) (0.47) (0.01)
Interest Coverage
9.00 18.86 7.19 0.13 (6.63) (12.33) (2.12) (2.78) (0.50) (1.75)
ROE
0.00% 47.52% 170.03% 82.56% (46.38%) (554.53%) 47.61% 75.81% (91.69%) 314.85%
ROA
0.00% (12.11%) (74.64%) 15.55% (22.60%) (75.82%) (13.28%) (6.59%) (3.78%) (10.70%)
ROIC
— 0.00% 0.00% (2.33%) (22.62%) (491.74%) (67.90%) (44.68%) (16.40%) (42.40%)
Return on Tangible Assets
0.00% (24.26%) (72.82%) 26.28% (53.96%) 847.75% 52.43% (849.11%) 41.79% 364.52%
Average Days of Receivables
0.00 24.27 74.60 35.32 48.47 24.79 19.04 17.99 14.17 25.37
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
60.36% 56.30% 58.98% 70.12% 82.22% 94.74% 56.24% 54.33% 45.24% 45.52%
Intangible Assets out of Total Assets
— 0.00 0.10 0.17 0.20 0.06 0.07 0.07 0.08 0.06
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 5.50% 8.76% 5.49% 4.11% 1.10% 0.00% 0.00%
Graham Net Nets
(0.75) (0.75) (0.75) (0.30) (0.51) (0.80) (2.33) (1.98) (3.81) (6.60)
Graham Number
0.00 0.00 0.00 0.00 0.00 9.44 2.51 0.00 0.00 —
Earnings Yield
7.48% 7.48% 7.48% 5.76% (29.60%) (69.83%) (29.51%) (63.11%) (68.16%) (69.53%)
Free Cash Flow Yield
0.00% 0.00% 0.00% 17.73% 10.05% 6.41% (72.04%) (95.18%) (182.61%) (333.00%)
Revenue per Share
3.67 4.30 8.40 8.18 6.00 4.55 3.65 2.20 2.20 2.10
Operating CF per Share
0.31 0.44 0.33 0.82 (0.01) 0.36 (0.41) 0.24 0.23 (0.04)
Capex per Share
0.00 0.00 (0.86) (0.72) (0.30) (0.23) (0.01) (0.18) (0.09) 0.00
Free Cash Flow per Share
0.31 0.44 (0.53) 0.10 (0.31) 0.13 (0.42) 0.06 0.14 (0.04)
Cash per Share
0.00 0.67 1.12 1.45 0.35 0.28 0.07 0.20 0.13 0.19
Shareholders Equity per Share
0.00 (0.30) (2.75) 5.56 2.83 (1.31) (0.69) 0.11 0.03 (0.13)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.00 (0.30) (2.75) 5.56 2.83 (1.31) (0.69) 0.11 0.03 (0.13)
Free Cash Flow
7.45 10.55 (7.22) 1.56 (6.66) 2.76 (11.41) 2.66 6.81 (1.76)
Working Capital
— 14.47 16.87 (0.09) (13.84) (66.33) (69.28) (42.36) (43.67) (40.92)
Capital Expenditures
(5.90) (7.05) (11.74) (11.00) (6.54) (5.16) (0.25) (7.83) (4.27) (0.06)
Net Current Asset Value
— (57.21) (97.15) (27.76) (58.86) (100.70) (88.37) (58.71) (54.08) (58.38)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.10 0.09 0.05 0.05 0.00 0.08 0.04 0.00
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.00 0.13 0.14 0.16 0.20 0.28 0.19 0.22 0.25 0.21
Cash ROIC
0.00% 12.61% (237.48%) 1.22% (6.35%) 14.28% (85.62%) 9.36% 35.18% (7.60%)
Accounts Receivable Turnover
0.00 12.51 7.58 7.05 8.85 8.29 16.61 19.39 23.80 18.17
Accounts Payable Turnover
20.69 21.94 16.45 17.24 14.09 11.99 7.93 7.87 9.14 9.35
Inventory Turnover
17.09 18.13 11.10 11.45 12.01 12.19 10.53 16.07 27.19 23.06
Average Days of Payables
6.49 27.15 20.27 22.51 34.43 30.33 54.26 42.93 42.25 32.64
Days of Inventory on Hand
(0.19) 40.45 29.85 34.55 34.10 29.66 32.33 15.77 13.02 17.66
Average Receivables
— 8.25 15.19 17.84 14.76 12.07 6.00 4.97 4.42 5.53
Average Payables
1.58 1.58 2.38 2.32 3.67 4.86 5.90 6.47 6.36 5.78
Average Inventory
1.91 1.91 3.52 3.49 4.31 4.78 4.44 3.17 2.14 2.34
Average Assets
— 93.65 51.11 126.87 150.97 119.92 85.31 80.21 73.43 69.35
Average Common Equity
— (23.87) (22.44) 23.89 73.57 16.40 (23.80) (6.98) 3.03 (2.36)

Fold the line items

Columns are period end dates